{
    "summary": "The Knock Out Cancer Act aims to increase funding for cancer research at the National Cancer Institute (NCI). The bill appropriates an additional 25% of the fiscal year 2022 NCI funding for each fiscal year between 2026 and 2030. It also mandates a study by the Secretary of Health and Human Services, through the FDA, to investigate the reasons behind cancer drug shortages, including economic factors, supply chain issues, and drug development/approval delays, with a report to Congress containing recommendations to address these shortages. The bill recognizes cancer's significant impact with findings highlighting its mortality rates and the importance of research investment.",
    "tags": [
        "Healthcare",
        "Healthcare access",
        "Public safety",
        "Economic stimulus",
        "Opioid crisis",
        "Elderly care",
        "Family services",
        "Research",
        "COVID-19 response"
    ],
    "category": "Healthcare & Public Health"
}